Retracted: Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine‐resistant pancreatic cancer cells in vitro and in vivo
Open Access
- 7 September 2010
- journal article
- retracted article
- Published by Wiley in International Journal of Cancer
- Vol. 128 (5), 1240-1250
- https://doi.org/10.1002/ijc.25658
Abstract
This article has been retracted at the request of: Editor‐in‐Chief and Co‐author ‘Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine‐resistant pancreatic cancer cells in vitro and in vivo’ by Banerjee, S., Kong, D., Azmi, A. S., Wang, Z., Ahmad, A., Sethi, S. and Sarkar, F. H. The above article, published online on 16 November 2010, in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor‐in‐Chief, Professor Peter Lichter, and Wiley Periodicals, Inc. A university investigation involving the first and corresponding author determined that several figures in this paper were mislabeled, manipulated, or duplicated and relabeled while processing/compiling the final figures assembled from the original data sources. Therefore, the authors are retracting the paper in its entirety although they maintain that these issues did not affect the major conclusions. They apologize for any inconvenience this may have caused. Reference Banerjee, S., Kong, D., Azmi, A. S., Wang, Z., Ahmad, A., Sethi, S. and Sarkar, F. H. (2011), Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine‐resistant pancreatic cancer cells in vitro and in vivo. Int. J. Cancer, 128: 1240–1250. doi: 10.1002/ijc.25658Funding Information
- National Institutes of Health (R01CA101870, R01CA101871, R01 CA101872, R01 CA101873)
This publication has 41 references indexed in Scilit:
- FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer CellsMolecular Cancer Research, 2010
- Harnessing the fruits of nature for the development of multi-targeted cancer therapeuticsCancer Treatment Reviews, 2009
- Oral Poly(ADP-Ribose) Polymerase-1 Inhibitor BSI-401 Has Antitumor Activity and Synergizes with Oxaliplatin against Pancreatic Cancer, Preventing Acute NeurotoxicityClinical Cancer Research, 2009
- 3,3′-Diindolylmethane Enhances Chemosensitivity of Multiple Chemotherapeutic Agents in Pancreatic CancerCancer Research, 2009
- RETRACTED: Sensitization of squamous cell carcinoma to cisplatin induced killing by natural agentsCancer Letters, 2009
- Perspectives for Cancer Prevention With Natural CompoundsJournal of Clinical Oncology, 2009
- Multi-targeted therapy of cancer by genisteinCancer Letters, 2008
- Treatment of Advanced Pancreatic CancerSeminars in Oncology, 2007
- Retracted:In vitroandin vivomolecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancerInternational Journal of Cancer, 2006
- Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathwaysBiochemical and Biophysical Research Communications, 2005